Kensai Health delivers senior-led regulatory medical writing, active biostatistical oversight, pharmacovigilance safety documents, and evidence synthesis. We turn complex clinical trial data into submission-grade regulatory narratives with zero bureaucracy.
Large CROs pitch seasoned leaders but delegate actual writing to junior, revolving staff. Kensai Health eliminates turnover, bridges data-writing silos, and ensures first-time-right regulatory quality.
From early trial protocol design to global registrational dossiers, pharmacovigilance safety documents, and high-impact medical publications.
Submission-grade Clinical Study Reports (ICH E3), Phase I–IV Protocols, Investigator's Brochures (IBs), eCTD Modules 2.4–2.7, 4 & 5 (ISS/ISE), and EU MDR Medical Device CERs/CEPs.
View Regulatory Services →Upstream SAP & Mock TLF co-design, biostatistics & Data Management vendor oversight, pre-DBL blind data reviews, and conversion of complex SAS outputs into clear regulatory narratives.
View Statistical Synergy →High-volume patient safety narratives (SAEs, AESIs, deaths), Development Safety Update Reports (DSURs), PSURs, PBRERs, and safety database software familiarity (Argus Safety).
View Safety Documents →High-impact scientific posters and abstracts for international congresses (ASCO, ESMO, EHA), executive slide decks for advisory boards and product launches, and visual aids.
View Medical Communications →Peer-reviewed manuscripts for indexed Q1/Q2 journals (ICMJE/GPP4), PRISMA-compliant Systematic Literature Reviews (SLR), Meta-Analyses with forest plots, and advanced quantitative research synthesis.
View Evidence Synthesis →